416 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Urinary Bladder Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Conditions: Locally Advanced or Metastatic Urothelial Cell Carcinoma;   Urinary Bladder Disease;   Urological Diseases
Interventions: Drug: B-701;   Drug: Docetaxel;   Drug: placebo
2 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Urinary Bladder Overactive;   Overactive Bladder;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
3 Recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
4 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
5 Recruiting Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Condition: Bladder Cancer
Intervention: Biological: Vicinium
6 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
7 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
8 Not yet recruiting Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder
Conditions: Urothelial Carcinoma;   Bladder Cancer
Interventions: Drug: Nivolumab in combination with Urelumab;   Drug: Urelumab monotherapy
9 Not yet recruiting Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)
Condition: Bladder Cancer
Intervention: Other: Vinflunine + Cisplatin + radical cystectomy
10 Not yet recruiting Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Conditions: Recurrent Bladder Urothelial Carcinoma;   Stage 0a Bladder Urothelial Carcinoma;   Stage 0is Bladder Urothelial Carcinoma;   Stage I Bladder Cancer With Carcinoma In Situ;   Stage I Bladder Urothelial Carcinoma
Interventions: Drug: Atezolizumab;   Other: Laboratory Biomarker Analysis
11 Not yet recruiting The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder Neoplasia
Condition: Bladder Cancer
Intervention: Device: Confocal LASER Endomicroscopy
12 Not yet recruiting Investigation of the Effect of the Female Urinary Microbiome on Incontinence
Conditions: Overactive Bladder;   Incontinence;   Nocturia
Intervention: Drug: Estrogen Cream
13 Not yet recruiting A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects
Condition: Overactive Bladder
Interventions: Drug: DA-8010;   Drug: Placebo
14 Not yet recruiting Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Drug: GSK1358820;   Drug: Placebo;   Drug: Antibiotic therapy;   Other: Bladder diary;   Other: King's Health Questionnaire (KHQ);   Other: Overactive Bladder Symptom Score (OABSS);   Other: Treatment Benefit Scale (TBS)
15 Not yet recruiting Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy
Conditions: Pelvic Radiation Therapy;   Radiation-induced Hemorrhagic Cystitis
Intervention: Other: Mesenchymal Stromal Cell (MSC) injections
16 Not yet recruiting Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients
Condition: Bladder Cancer
Intervention: Other: without intervention
17 Not yet recruiting Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer
Conditions: Recurrent Bladder Carcinoma;   Stage 0a Bladder Urothelial Carcinoma;   Stage 0is Bladder Urothelial Carcinoma;   Stage I Bladder Cancer
Interventions: Biological: BCG Solution;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Other: Pharmacological Study
18 Recruiting The Effect of Atezolizumab in Combination With Gemcitabine/Carboplatin and Gemcitabine/Carboplatin Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-based Therapy [IMvigor130]
Condition: Bladder Cancer, Urothelial Carcinoma
Interventions: Drug: Atezolizumab;   Drug: Carboplatin;   Drug: Gemcitabine;   Other: Placebo
19 Not yet recruiting uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Drug: Injection of 18F-FDG;   Device: Positron Emission Tomography and CT;   Device: Positron Emission Tomography and MRI
20 Not yet recruiting Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer
Condition: Overactive Bladder
Interventions: Drug: Succinate of Solifenacin;   Drug: Placebo of Succinate of Solifenacin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years